Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 1/20 | 0.37 |
| ▸ | TDO2 | P48775 | 1/20 | 0.37 |
| ▸ | TACR1 | P25103 | 12/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | METAP2 | P50579 | 1/20 | 0.33 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.33 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.33 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.33 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5909720 | 0.84 | ALDH1A1 (0.48) | ALDH1A1TSHRKIF11P2RX1IDO1 | |
| SCHEMBL15065839 | 0.84 | ALDH1A1 (0.48) | ALDH1A1TSHRKIF11P2RX1IDO1 | |
| Benzene SCHEMBL30336225 | 0.84 | TSHR (0.43) | ALDH1A1TSHRKIF11P2RX1IDO1 | |
| SCHEMBL41567 | 0.79 | CES2 (0.44) | ALDH1A1TSHRKIF11IDO1 | |
| Aniline SCHEMBL1010731 | 0.79 | ALDH1A1 (0.43) | ALDH1A1TSHRKIF11P2RX1IDO1 | |
| SCHEMBL6387404 | 0.78 | ALDH1A1 (0.41) | ALDH1A1TSHRKIF11P2RX1IDO1 | |
| SCHEMBL8025648 | 0.78 | TSHR (0.46) | ALDH1A1TSHRKIF11P2RX1IDO1 | |
| Toluene SCHEMBL6239727 | 0.78 | TSHR (0.41) | ALDH1A1TSHRKIF11P2RX1IDO1 | |
| SCHEMBL134407 | 0.78 | ALDH1A1 (0.41) | ALDH1A1TSHRKIF11P2RX1IDO1 | |
| Toluene SCHEMBL6538388 | 0.78 | TSHR (0.41) | ALDH1A1TSHRKIF11P2RX1IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 833 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11760814-B2 | 1,5 diazabicyclooctane ligand systems and methods therewith | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-09-19 | — | — | US | claimed |
| EP-4222180-A1 | BIS(HETEROCYCLIC-OLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2023-08-09 | — | — | EP | claimed |
| EP-4196507-A1 | CYCLIC CONTAINING POLYMER COMPOSITIONS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND PROCESS FOR PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2023-06-21 | — | — | EP | claimed |
| CN-113423744-B | Lewis base catalyst and method thereof | 埃克森美孚化学专利公司 | 2023-05-05 | — | — | CN | claimed |
| EP-4103630-A1 | PROPYLENE COPOLYMERS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND HOMOGENEOUS PROCESS FOR PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2022-12-21 | — | — | EP | claimed |
| EP-4103631-A1 | ETHYLENE-ALPHA-OLEFIN-DIENE MONOMER COPOLYMERS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND HOMOGENEOUS PROCESS FOR PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2022-12-21 | — | — | EP | claimed |
| EP-4103628-A1 | PROPYLENE POLYMERS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND HOMOGENEOUS PROCESS FOR PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2022-12-21 | — | — | EP | claimed |
| EP-4103629-A1 | POLYETHYLENE COMPOSITIONS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND HOMOGENEOUS PROCESS FOR PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2022-12-21 | — | — | EP | claimed |
| CN-114867758-A | Metallocenes and methods thereof | 埃克森美孚化学专利公司 | 2022-08-05 | — | — | CN | claimed |
| EP-4017887-A1 | ISOTACTIC PROPYLENE HOMOPOLYMERS AND COPOLYMERS PRODUCED WITH C1 SYMMETRIC METALLOCENE CATALYSTS | ExxonMobil Chemical Patents Inc. (US) | 2022-06-29 | — | — | EP | claimed |
| US-20050239981-A1 | Phosphorus bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-10-27 | — | — | US | claimed |
| US-20050239980-A1 | Phosphorus substituted metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-10-27 | — | — | US | claimed |
| EP-1546223-A2 | SUPERCRITICAL POLYMERIZATION PROCESS AND POLYMERS PRODUCED THEREFROM | ExxonMobil Chemical Patents Inc. (US) | 2005-06-29 | — | — | EP | claimed |
| EP-1521758-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2005-04-13 | — | — | EP | claimed |
| US-20040266961-A1 | Catalyst composition II | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-12-30 | — | — | US | claimed |
| WO-2004106390-A2 | POLYMERIZATION AND OLIGOMERIZATION CATALYST WITH TRIDENTATE OR TETRADENTATE LIGAND | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-12-09 | — | — | WO | claimed |
| WO-2004026923-A9 | SUPERCRITICAL POLYMERIZATION PROCESS AND POLYMERS PRODUCED THEREFROM | EXXONMOBIL CHEM PATENTS INC (US) | 2004-09-10 | — | — | WO | claimed |
| US-20040122191-A1 | Supercritical polymerization process and polymers produced therefrom | EXXONMOBIL CHEMICAL PATENTS INC | 2004-06-24 | — | — | US | claimed |
| WO-2004026923-A2 | SUPERCRITICAL POLYMERIZATION PROCESS AND POLYMERS PRODUCED THEREFROM | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-04-01 | — | — | WO | claimed |
| WO-2004007509-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-01-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11760814-B2 | 1,5 diazabicyclooctane ligand systems and methods therewith | ODC1, DDT, OXGR1 | ALDH1A1 189/4885TSHR 4711/4885KIF11 3591/4885 |
| US-20050239981-A1 | Phosphorus bridged metallocene compounds for olefin polymerization | PYM1, ZNF207, POLL | ALDH1A1 4206/4885TSHR 3182/4885KIF11 2934/4885 |
| US-20040266961-A1 | Catalyst composition II | MLX, CBX2, BMX | ALDH1A1 4593/4885TSHR 4496/4885KIF11 3881/4885 |
| US-20050239980-A1 | Phosphorus substituted metallocene compounds for olefin polymerization | CCRL2, ARL1, OSBP2 | ALDH1A1 4248/4885TSHR 2600/4885KIF11 3768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.